Fosaprepitant Dimeglumine 150 mg/vial Suppliers & Bulk Manufacturers
Available Forms: Injection (IV)
Available Strengths: 150 mg/vial
Reference Brands: Emend® IV (EU & US)
Category: Oncology Cancer Care
Fosaprepitant Dimeglumine is used in oncology to prevent chemotherapy-induced nausea and vomiting. Available as a 150 mg IV injection in both the US and EU.
Product Description:
Fosaprepitant Dimeglumine is a trusted NK1 receptor antagonist used in oncology supportive care to prevent chemotherapy-induced nausea and vomiting (CINV). Available as a 150 mg intravenous injection, Fosaprepitant is commonly co-administered with 5-HT3 antagonists and corticosteroids. It enhances patient comfort and compliance during highly or moderately emetogenic chemotherapy. Approved in both the US and EU, and marketed under Emend® IV and as generics, it is widely used in hospital oncology departments and pharma B2B distribution. Reliable and effective, Fosaprepitant plays a critical role in managing CINV, improving quality of life for cancer patients receiving chemotherapy.
Fosaprepitant Dimeglumine — third party manufacturing & bulk supply
Fosaprepitant Dimeglumine 150 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Fosaprepitant Dimeglumine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Fosaprepitant Dimeglumine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Fosaprepitant dimeglumine injection is used for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, including high-dose cisplatin, and moderately emetogenic chemotherapy. It is administered intravenously as part of combination antiemetic therapy.
Fosaprepitant dimeglumine injection is made from fosaprepitant dimeglumine, which is a prodrug of aprepitant. It is a neurokinin-1 (NK1) receptor antagonist that works by blocking the action of substance P in the brain, thereby preventing chemotherapy-induced nausea and vomiting.
The most well-known trade name is Emend for Injection.
Emend for Injection is marketed by Merck & Co., Inc. Generic fosaprepitant dimeglumine injection is also manufactured by multiple pharmaceutical companies worldwide depending on regulatory approvals.
The generic name is fosaprepitant dimeglumine.
The brand name is Emend for Injection.
Fosaprepitant dimeglumine injection is manufactured in GMP-certified pharmaceutical facilities in the United States, Europe, India, and other regulated markets depending on the marketing authorization holder and supplier. Specific manufacturing locations vary by brand and batch.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
